Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended	1 Months Ended	6 Months Ended
	Oct. 27, 2013 Successor	Jun. 07, 2013 Predecessor	Oct. 28, 2012 Predecessor
Cash Flows from Operating Activities:
Net (loss)/income	$ (38,489)	$ (192,697)	$ 556,266
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation	114,330	35,880	147,334
Amortization	29,821	4,276	21,075
Amortization of deferred debt issuance costs	18,807	867	2,333
Inventory fair value step-up charged to cost of products sold	383,300	0	0
Deferred tax benefit	(257,990)	(20,492)	(60,101)
Net loss on divestitures	0	0	20,915
Pension contributions	(105,857)	(6,812)	(31,701)
Unrealized gain on derivative instruments	(117,934)	0	0
Other items, net	13,854	23,706	14,623
Changes in current assets and liabilities, excluding effects of acquisitions and divestitures:
Receivables (includes proceeds from securitization)	(36,558)	(3,360)	(148,839)
Inventories	26,228	(183,413)	(241,878)
Prepaid expenses and other current assets	21,611	(18,411)	(7,022)
Accounts payable	(79,527)	(69,825)	95,077
Accrued liabilities	(30,724)	48,025	(51,899)
Income taxes	(70,433)	10,163	(24,906)
Cash (used for)/provided by operating activities	(129,561)	(372,093)	291,277
Cash Flows from Investing Activities:
Capital expenditures	(98,833)	(120,154)	(175,673)
Proceeds from disposals of property, plant and equipment	4,332	108	15,133
Proceeds from divestitures	25,987	0	16,777
Acquisition of business, net of cash on hand	(21,494,287)	0	0
Other items, net	(4,478)	30,251	(7,500)
Cash used for investing activities	(21,567,279)	(89,795)	(151,263)
Cash Flows from Financing Activities:
Payments on long-term debt	(2,663,521)	(439,747)	(208,728)
Proceeds from long-term debt	12,568,875	1,521	198,419
Debt issuance costs	(320,824)	0	0
Net (payments)/proceeds on commercial paper and short-term debt	(1,647,305)	480,672	19,996
Dividends	(180,000)	0	(333,349)
Exercise of stock options	0	886	60,664
Purchase of treasury stock	0	0	(80,016)
Acquisitions of subsidiary shares from noncontrolling interest	0	0	(80,132)
Capital contributions	16,500,000		0
Other items, net	31,199	42,086	1,536
Cash provided by/(used for) financing activities	24,288,424	85,418	(421,610)
Effect of exchange rate changes on cash and cash equivalents	(1,429)	(30,262)	(41,643)
Net increase/(decrease) in cash and cash equivalents	2,590,155	(406,732)	(323,239)
Cash and cash equivalents at beginning of year			1,330,441
Cash and cash equivalents at end of period	$ 2,590,155	$ 2,069,967	$ 1,007,202